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Research
Polybrominated diphenyl ethers (PBDEs) are
used as flame retardants in electronic equip-
ment, home furnishings, textiles, and con-
struction materials. They are similar to
polychlorinated biphenyls (PCBs) in structure
and in their persistence and bioaccumulative
properties (Birnbaum and Staskal 2004). Over
the last 20 years, PBDE levels have increased
in human samples, whereas PCBs have
declined (Schecter et al. 2005).
Because PBDEs are similar in structure to
thyroxine (T4) and triiodothyronine (T3)
(Hamers et al. 2006), concerns have been
raised regarding their effect on thyroid func-
tion, which is regulated by the hypothalamo–
pituitary–thyroid axis and inﬂuences develop-
ment and gene expression in vertebrates
(Zoeller et al. 2007). Reduction of circulating
thyroid hormone is compensated for by release
of thyroid-releasing hormone from the hypo-
thalamus, which in turn increases thyroid-
stimulating hormone (TSH) release from the
pituitary, ultimately stimulating thyroid hor-
mone production. T4 and T3 are transported
to peripheral tissues bound to proteins, pri-
marily T4-binding globulin (TBG), but also to
albumin and transthyretin (TTR). TBG pro-
duction is stimulated by estrogen and inhibited
by testosterone. T4 is the major hormone pro-
duced by the thyroid. Some T3 is produced
directly by the thyroid, but most is derived
from peripheral deiodination of T4. T3 and T4
are primarily metabolized by deiodination to
diiodothyronine and reverse T3 (rT3), with
some metabolism through glucuronidation,
sulfonation, and other pathways. This complex
system is vulnerable to disruption by a variety
of chemicals through changes in hormone pro-
duction, transport, and/or metabolism (Zoeller
et al. 2007).
Biologic effects of PBDEs in rodents are
similar to those of PCBs, with increased risks
for reproductive and endocrine disruption
(Ellis-Hutchings et al. 2006; Lilienthal et al.
2006; Stoker et al. 2004; Zhou et al. 2002),
and neurodevelopmental problems (Kuriyama
et al. 2005). In humans, PCBs have been asso-
ciated with disruption of thyroid hormone
homeostasis (Langer et al. 2007; Persky et al.
2001; Turyk et al. 2007), but the effects of
PBDEs on thyroid hormones have been inves-
tigated only in a few smaller studies (Bloom
et al. 2008; Hagmar et al. 2001; Julander et al.
2005; Yuan et al. 2008).
In 2001, we reported that PCBs were asso-
ciated with lower levels of T4 and free T4 index
in women and T4 and sex-hormone–binding
globulin (SHBG)-bound testosterone in men
from a cohort of frequent and infrequent
Great Lakes fish consumers (Persky et al.
2001). In 2003, we invited participants from
the original cohort to participate in a follow-up
study to explore potential mechanisms by
which PBDEs, PCBs, and p,p´-diphenyl-
dichloroethene (DDE) might be affecting thy-
roid hormone balance. In addition to the
standard hormones (free and total T4 and T3,
as well as TSH), we explored via additional
laboratory parameters speciﬁc mechanisms of
action suggested by laboratory studies, such as
changes in transport by serum-binding pro-
teins (Hallgren et al. 2001; Hamers et al.
2006) and increase in thyroglobulin antibodies
(Langer et al. 2007). In this study we explored
the relationship of PBDE exposure with hor-
mone homeostasis, thyroglobulin antibodies,
and thyroid disease in men. Associations of
thyroid hormones with PCB congeners and
DDE will be reported separately. 
Materials and Methods
Study participants. We invited a cohort of
4,206 frequent and infrequent consumers of
Great Lakes ﬁsh established during the early
1990s (Hanrahan et al. 1999) to participate in
a follow-up study. Information on fish con-
sumption, medical diseases, and use of pre-
scription and over-the-counter medications
and vitamin supplements, and blood and
urine samples were collected from 354 men
during 2003–2004. Blood was collected into
red-top tubes and allowed to clot for
20–30 min. Serum for exposure analyses was
transferred to hexane-rinsed glass tubes and
frozen. Serum and urine samples for hormone
assays were frozen in polypropylene tubes. In
addition, stored serum samples collected from
51 men in 2001–2003 were analyzed for hor-
mone and exposure levels. The study protocol
was approved by institutional review boards at
the University of Wisconsin, Madison, and
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BACKGROUND: Persistent pollutants, such as polychlorinated biphenyls (PCBs), affect endocrine
function. Human exposure to polybrominated diphenyl ethers (PBDEs), which are similar in struc-
ture to PCBs, has increased recently, but health effects have not been well studied.
OBJECTIVES: Our goal in this study was to determine whether PBDE body burdens are related to
thyroid and steroid hormone levels, thyroid antibodies, and thyroid disease in a cohort of frequent
and infrequent adult male sport ﬁsh consumers.
METHODS: We tested serum from 405 adult males for PBDE congeners, PCB congeners, testos-
terone, sex-hormone–binding globulin (SHBG), SHBG-bound testosterone, thyroglobulin antibod-
ies, and the thyroid hormones thyroxine (T4), triiodothyronine (T3), thyroid-stimulating hormone
(TSH), and T4-binding globulin (TBG). We collected data on demographics, ﬁsh consumption,
medical diseases, and medication use.
RESULTS: The median sum of PBDEs was 38 ng/g lipid. In 308 men without thyroid disease or
diabetes, PBDEs were positively related to measures of T4 and reverse T3 and inversely related to
total T3 and TSH. PBDEs were positively related to the percentage of T4 bound to albumin, and
inversely related to the percentage of T4 bound to TBG. Associations of BDE congeners with hor-
mones varied. BDE-47 was positively associated with testosterone levels. Participants with PBDEs
over the 95th percentile were more likely to have thyroglobulin antibodies, although high PBDE
exposure was not associated with thyroid disease. PBDE effects were independent of PCB exposure
and sport ﬁsh consumption.
CONCLUSIONS: PBDE exposure, at levels comparable with those of the general U.S. population, was
associated with increased thyroglobulin antibodies and increased T4 in adult males.
KEY WORDS: brominated ﬂame retardants, hormone, PBDEs, sex hormone binding globulin, sport
ﬁsh, testosterone, thyroglobulin antibodies, thyroid hormone. Environ Health Perspect 116:1635–1641
(2008). doi:10.1289/ehp.11707 available via http://dx.doi.org/ [Online 24 July 2008]the University of Illinois at Chicago, and all
subjects gave written informed consent before
participation.
Exposure analyses. Serum samples were
tested for PBDEs, PCBs, and DDE by the
Wisconsin State Laboratory of Hygiene as pre-
viously described (Anderson et al. 2008).
Brieﬂy, sera were extracted with hexane/ethyl
ether, with cleanup and fractionation using
Florisil, silica gel, and concentrated sulfuric acid.
PBDEs were analyzed by gas chromatography–
mass spectrometry (GC-MS), and PCBs and
DDE by GC. Quality control was monitored
by the use of method blanks, spikes of bovine
serum, duplicates of bovine serum spikes or
sample duplicates, surrogate spikes, and conﬁr-
mation of the analytes by second column or
GC-MS, as appropriate. Mean recoveries were
76–91% for 24 tri- to decaBDE congeners,
97% for DDE, and 81–94% for di- to
hexaPCB congeners.
Hormone analyses. Hormone assays were
performed on serum and urine samples at
Northwestern University in R.C.’s laboratory.
Total T4 (serum and urine), total T3, and the
free unbound concentrations of these thyroid
hormones were measured by radioimmunoassay
(Diagnostic Products Corporation, Inc., Los
Angeles, CA). Speciﬁcity was > 99%. Interassay
and intraassay coefﬁcient of variations (CVs)
were, respectively, 3.0% and 3.3% for total T3,
4.0% and 5.0% for total T4, 6.9% and 4.3%
for free T4, 28.8% and 7.9% for free T3, and
5.6% and 14.9% for urinary total T4. We meas-
ured rT3 in a competitive radioimmunoassay
with a sensitivity of 7.0 ng/dL (ALPCO
Diagnostics, Windham, NH). The antiserum
used was highly speciﬁc: T3 and T4 cross-react
by < 0.1%. Interassay and intraassay CVs were
13.4% and 5.5%, respectively.
We measured TSH and TBG in the
Immulite System (Diagnostic Products). The
TSH assay had a sensitivity of 0.002 µIU/mL
and was highly specific, with < 0.1% cross-
reaction with other glycoprotein hormones.
The TBG assay was also highly speciﬁc, with a
sensitivity of 1.1 µg/mL. Interassay CVs were
14.7% for TSH and 9.7% for TBG.
We examined the distribution of T4 bind-
ing in plasma by radioelectrophoresis (Borst
et al. 1982; Leopold et al. 1987). We sepa-
rated albumin- and TBG-bound 125I-T4 on
agarose gels after incubation of 125I-T4 with
the serum for 2 hr at 37°C. TTR, which we
did not quantify in this analysis, is clearly
separated from TBG in this system. The gels
were stained with bromothymol blue to iden-
tify albumin in the samples. Standards of
TBG and TTR were run in parallel to deter-
mine the location relative to albumin on the
gel. The areas corresponding to TBG and
albumin were cut out of the gel and counted
in a gamma counter, and the percentage of the
total 125I-T4 in each fraction was determined.
Interassay CVs were 3.4% for TBG-bound T4
and 11.9% for albumin-bound T4.
We measured urine creatinine spec-
trophotometrically by the Jaffe reaction after
ethyl ether extraction. Interassay and intra-
assay CVs were 9.3% and 5.6%, respectively.
We measured testosterone in serum using
a coated tube assay that employs 125I-labeled
testosterone as the tracer (Diagnostic Systems
Laboratories, Webster, TX). The antiserum
cross-reacted < 0.9% with androstenedione
and androstenediol and 5.8% with dihydro-
testosterone. Interassay and intraassay CVs
were 17.0% and 6.6%, respectively. We
measured SHBG using a competitive radio-
immunoassay with a sensitivity of 5 nmol/L
(Diagnostic Systems Laboratories). The
interassay and intraassay CVs were 15.7%
and 6.6%, respectively.
SHBG-bound testosterone was deter-
mined as described by Bonfrer et al. (1989).
We equilibrated a 0.2-mL volume of serum
diluted 1/8 with buffer with 3H-estradiol
overnight at 4°C. A 0.10 mL suspension of a
conconavalin-A (Con-A) Sepharose conjugate
was added to the serum. SHBG was allowed
to bind to the Con-A during a 30-min incuba-
tion period at room temperature. Testosterone
in the serum maintains its equilibrium con-
centration with SHBG in the presence of
endogenous factors such as other androgens,
estrogens, and free fatty acids (Bonfrer et al.
1989; Street et al. 1989). Separation of
unbound 3H-testosterone from that bound to
the Sepharose Con-A was achieved by cen-
trifugation at 0°C to minimize dissociation of
bound estradiol. The interassay and intraassay
CVs were 4.5% and 3.6%, respectively.
Thyroglobulin antibodies and hemoglo-
bin A1c (HA1c) were measured by Quest
Diagnostics (Auburn Hills, MI, and Wood
Dale, IL). HA1c was measured by afﬁnity chro-
matography, which measured total glycosylated
hemoglobin, from which HA1c is calculated.
Thyroglobulin antibodies were detected in an
immunochemiluminometric assay that used
avidin beads, biotinylated thyroglobulin, and
acridinium ester–labeled thyroglobulin. Total
cholesterol and triglycerides were measured by
Quest Diagnostics for samples collected in
2004–2005 and by Meriter Laboratories
(Madison, WI) for samples collected in
2001–2003. Total serum lipids were calculated
by the following formula: total cholesterol
(mg/dL) × 2.27 + triglycerides (mg/dL) + 62.3.
Statistical analyses. For results below the
limit of detection (LOD), we imputed BDE
and PCB congener concentrations as the LOD
for the individual congener divided by 2. We
summed BDE congeners 28, 47, 49, 85,
99, 100, 138, and 153 to derive ΣPBDEs.
Similarly, ΣPCB included PCB congeners 66,
74, 99, 118, 128, 146, 167, 172, 177, 178,
180, 183, 193, 194, 201, and 206, as well as
coeluting congeners 163/138, 170/190,
203/196, 202/171, 208/195, 187/182, and
132/153/105. We used natural log transforma-
tions (ln) of ΣPBDEs, BDE-47, ΣPCBs, DDE,
TSH, rT3, free T3, urinary T4, and SHBG to
approximate a normal distribution.
We explored associations of thyroglobulin
antibodies and thyroid disease with ΣPBDEs
greater than the 90th or 95th percentiles in
the full cohort of 405 men using logistic
regression models, with adjustment for age.
Participants were excluded from the hor-
mone analyses if they reported medical condi-
tions or medication use known to affect
thyroid hormone levels (Meier and Burger
2005). Complete data for exposure and hor-
mone measures were available for 308 men for
the hormone analysis after excluding partici-
pants missing data for lipids (n = 12); using
thyroid hormones or having thyroid disease
(n = 21); using blood-glucose–regulating med-
ications or having diabetes (n = 60); using
other hormones (n = 11; testosterone, systemic
corticosteroids, melatonin, human growth
hormone); or using other medications known
to affect thyroid hormones (n = 4; dilantin,
tegretol, lithium, carbodopa).
Associations of hormones with ΣPBDEs
and BDE-47 were modeled using linear
regression, and Pearson’s partial correlation
coefﬁcients for associations of hormones with
exposures were estimated with the same vari-
ables used in the linear regression models. We
considered age, body mass index (BMI), and
serum lipids to be important covariates and
included them in all multivariate models.
Other potential confounding variables were
added individually to these models to deter-
mine if their inclusion affected the conclusion
about the signiﬁcance of the PBDE/hormone
association (p < 0.05 or p > 0.05). Factors that
were evaluated as potential confounders
included smoking, alcohol use, medication use
(antilipids, beta blockers, furosamide), Great
Lakes sport ﬁsh meals in the past year, sport
fish meals in the past year, ΣPCBs, DDE,
years consuming sport fish meals, years con-
suming Great Lakes sport fish meals, and
HA1c level. We also considered measured
levels of testosterone, SHBG, and SHBG-
bound testosterone as potential confounders
for thyroid hormone analyses.
We examined modiﬁcation of the effect of
ΣPBDEs on hormones by other exposure
covariates (all potential confounding variables
noted above) in linear regression models that
included multiplicative interaction terms for
ΣPBDEs and the potential effect modifier,
adjusting for age, BMI, and lipids. We did not
evaluate covariates identified as effect modi-
ﬁers (p < 0.05 for interaction term) as poten-
tial confounders, but we stratified models of
the effects of ΣPBDEs on hormones by above
and below median levels of the effect modiﬁer.
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extreme hormone values, we estimated models
after exclusion of participants with values more
than three interquartile ranges above the 75th
percentile or below the 25th percentile for hor-
mone measures. Models were also reestimated
using a variable for ΣPBDEs where congeners
below the LOD were imputed as 0, but this
did not affect our ﬁndings.
We designed this study to explore associa-
tions of PBDEs with standard thyroid hor-
mone parameters, free and total T4 and T3, as
well as TSH, and also with additional labora-
tory parameters to test speciﬁc mechanisms of
action. We explored patterns in the associa-
tions of PBDEs with thyroid hormones
regarding congener-specific associations and
independence of associations to examine
mechanistic hypotheses.
We estimated dose–response models by
linear regression for BDE congeners 47, 99,
100, and 153 using either indicator variables
for tertiles 2 and 3, with tertile 1 as the refer-
ence category, or the ordinal tertile variable to
test for a trend over the categories. For BDEs
99, 100, and 153, the lowest tertile included
all participants with measurements < LOD.
BDE tertiles (ng/g) were defined as follows:
BDE-47, < LOD to 0.08 (n = 106),
> 0.08–0.15 (n = 101), > 0.15 (n = 101);
BDE-99, < LOD (n = 117), 0.025–0.046 (n =
97), > 0.046 (n = 94); BDE-100, < LOD (n =
205), 0.026–0.05 (n = 52), > 0.05 (n = 51);
BDE-153, < LOD (n = 212), 0.05–0.099 (n =
49), > 0.099 (n = 47). We examined similar
models for ΣPBDE quartiles.
Because an effect of PBDEs at one point in
thyroid homeostasis could potentially change
other related thyroid hormone parameters, we
examined the independence of signiﬁcant asso-
ciations of thyroid hormones with ΣPBDEs
regarding other measured thyroid hormones.
When we identified a significant association
between ΣPBDEs and a thyroid hormone, we
further adjusted the linear regression model for
other thyroid hormone levels individually.
When the β-coefﬁcient for ΣPBDEs changed
by > 20% after adjustment for a second hor-
mone, this suggested that the effect of ΣPBDEs
on the original hormone may be related to or
mediated by the second hormone.
Results
Characteristics of the cohort included in the
hormone analysis are shown in Table 1. Most
men drank alcohol at least once a month
(78%), but few smoked cigarettes (11%), and
medication use varied, with 33% using anti-
lipidemics, 17% using beta blockers, and 3%
using furosamide (data not shown). Levels of
ΣPBDEs in the men were similar to those
found for a large sample representative of the
U.S. population of similar age and ethnicity: in
this study, geometric mean = 27 ng/g lipid
[95% confidence interval (CI), 24–30 ng/g
lipid]; in the National Health and Nutrition
Examination Survey, geometric mean =
34 ng/g lipid (95% CI, 27–43 ng/g lipid)
(Anderson et al. 2008). However, levels of
ΣPCBs were somewhat higher in the present
study than in the National Health and
Nutrition Survey (Anderson et al. 2008).
Because we excluded men with thyroid disease,
thyroid hormone levels were predominantly
within normal ranges (Table 1).
ΣPBDEs was significantly and positively
associated with several thyroid hormones,
including total T4, free T4, urinary T4, rT3,
and albumin-bound T4 (only after exclusion of
two extreme outliers) and was negatively asso-
ciated with TSH, but only after control for
sport ﬁsh consumption (Table 2). We found
generally similar associations for these thyroid
hormones with BDE-47, the dominant BDE
congener (Table 2).
Figure 1 shows dose–response models for
quartiles of ΣPBDEs. We saw the strongest
dose response for urinary T4, whereas only
the highest ΣPBDE quartile was elevated for
free T4 and rT3. Total T3, which was not sig-
niﬁcantly associated in the continuous analy-
sis (Table 2), was significantly negatively
associated with ΣPBDE quartiles. On the
other hand, total T4 and TSH were not sig-
nificantly associated with ΣPBDEs in the
ordinal dose–response models. The effect of
ΣPBDEs on T4 binding to serum proteins
was limited to the highest exposure quartile.
Urinary T4 was the only hormone associ-
ated with all four BDE congeners (Table 3).
rT3, total T4, and free T4 were positively
associated with BDE-99 and BDE-153, total
T3 was negatively associated with BDE-47
and BDE-153, and free T3 was negatively
associated with BDE-153. BDE-100 was neg-
atively associated with TBG-bound T4 and
positively associated with albumin-bound T4,
with similar associations for BDE-153, but
only in the highest tertile (Table 3).
We found signiﬁcant associations among
many of the thyroid hormone measurements
(data not shown). Because an effect of PBDEs
at one point in thyroid homeostasis could
potentially change other related thyroid hor-
mone parameters, we examined the indepen-
dence of significant associations of thyroid
hormones with ΣPBDEs regarding other meas-
ured thyroid hormones (Table 4). The associa-
tions of urinary T4 and albumin-bound T4
with ΣPBDEs were independent of other thy-
roid hormones (Table 4). However, associa-
tions of ΣPBDEs with rT3, free T4, total T4,
PBDEs and hormones in adult males
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Table 1. Distribution of covariates, exposure measures, and endogenous hormone levels in 308 men.
Percentile
Characteristic Mean Minimum 25th 50th 75th 95th Maximum
Age (years) 59 30 53 59 67 74 82
BMI (kg/m2) 29.8 18.4 26.8 29.2 32.0 38.4 50.2
Serum lipids (mg/dL) 720.8 370.1 600.1 693.6 810.0 976.6 2459.1
Urinary creatinine (μg/mL) 1402.4 65.8 843.3 1268.1 1877.3 2753.8 7290.3
HA1c (%) 5.6 4.4 5.4 5.6 5.9 6.5 8.8
ΣPBDEsa (ng/g lipid) 69.9 15.8 29.3 38.4 62.4 193.4 1360.2
ΣPBDEsa (ng/g) 0.47 0.13 0.20 0.26 0.41 1.49 10.15
BDE-47a (ng/g) 0.22 0.01 0.07 0.11 0.18 0.89 5.90
BDE-99a (ng/g) 0.06 0.01 0.01 0.03 0.05 0.16 2.60
BDE-100a (ng/g) 0.04 0.01 0.01 0.01 0.03 0.17 0.87
BDE-153a (ng/g) 0.08 0.03 0.03 0.03 0.07 0.30 2.30
ΣPCBsa (ng/g) 4.10 1.17 2.04 2.99 5.03 10.72 28.12
DDEa (ng/g) 3.29 0.08 1.20 2.10 4.00 10.00 20.00
Years eating sport ﬁsh 38 0 25 40 50 62 70
Years eating Great Lakes sport ﬁsh 32 0 20 33 50 60 70
Sport ﬁsh meals in last 12 months 29 0 4 18 40 104 265
Great Lakes sport ﬁsh meals  23 0 2 14 34 72 156
in last 12 months
TSHb (μIU/mL) 1.82 0.29 1.04 1.55 2.25 4.00 9.30
Total T3
b (ng/dL) 99.0 55.6 89.5 99.0 108.1 123.3 145.9
Free T3
b (pg/mL) 2.28 0.85 1.67 2.08 2.64 3.91 11.02
rT3 (ng/dL) 25.9 9.1 18.3 22.7 27.0 41.0 245.5
Total T4
b (μg/dL) 7.2 3.3 6.4 7.1 8.0 9.0 10.6
Free T4
b (ng/mL) 1.19 0.62 1.01 1.19 1.35 1.60 1.82
Urinary Total T4 (pg/mL) 1216.9 68.6 581.5 1084.7 1522.5 3033.3 5567.7
TBGb (μg/mL) 19.1 1.5 16.4 18.8 21.0 27.0 43.7
TBG-bound T4 (%) 77.3 49.5 74.4 77.7 80.8 84.4 90.9
Albumin-bound T4 (%) 17.7 5.9 14.7 17.2 20.2 25.9 46.2
Testosterone (ng/mL) 3.08 0.10 2.28 2.93 3.85 5.24 6.33
SHBG (nmol/L) 169.6 0 88.3 142.4 221.2 421.5 630.0
SHBG-bound testosterone (%) 32.5 0.2 27.5 32.0 37.5 44.7 54.4
aFor BDE and PCB congeners and DDE, we imputed values < LOD as the LOD for each analyte/2: LOD = 0.025 ng/g for
BDEs 28, 47, 49, 85, 99, and 100; LOD = 0.05 ng/g for BDEs 138 and 153. Proportion of samples > LOD: BDE-47 = 98%, BDE-99
= 62%, BDE-100 = 33% and BDE-153 = 31%. bNormal reference range: TSH = 0.5–4.7 μIU/mL, total T3 = 70–195 ng/dL, free T3
= 1–4.2 pg/mL, total T4 = 5–12 μg/dL, free T4 = 0.8–2 ng/mL, TBG = 13–39 μg/mL. total T3, and TSH were independent of many
but not all other thyroid hormone levels.
The effect of PBDEs on rT3, free T4, TBG-
bound T4, and albumin-bound T4 was signiﬁ-
cantly modiﬁed by HA1c levels, with stronger
associations in persons with higher HA1c levels
(data not shown). Effects of PBDEs on rT3 and
albumin-bound T4 were stronger among infre-
quent sport ﬁsh consumers, whereas effects on
TSH were stronger among frequent consumers
(data not shown). We found no evidence of
effect modiﬁcation by PCBs or DDE, years of
sport ﬁsh consumption, medication use, age,
BMI, serum lipids, smoking, alcohol use, or
steroid hormone levels.
Testosterone, SHBG, and SHBG-bound
testosterone were not associated with ΣPBDEs
or BDE-47 as a continuous variable (Table 2),
but the ordinal variable for BDE-47 tertiles
was positively associated with testosterone
(Table 3).
We studied thyroid disease and thyro-
globulin antibodies in the entire cohort of
405 men. Thyroglobulin antibodies were pre-
sent in 7.8% of the full cohort and in 31.3% of
those whose ΣPBDEs exceeded the 95th per-
centile [odds ratio (OR) = 6.1; Table 5]. High
PBDE exposure was not signiﬁcantly associated
with a diagnosis of thyroid disease (Table 5).
Discussion
Exposure to PBDEs at levels comparable with
those in the general U.S. population was asso-
ciated with thyroid and steroid hormone levels
in adult men without thyroid disease or dia-
betes. PBDEs were positively related to mea-
sures of T4 (total T4, free T4, urinary T4) and
rT3, and inversely related to total T3 and TSH.
PBDEs were positively related to the percent-
age of T4 bound to albumin and inversely
related to the percentage of T4 bound to TBG.
Associations of BDE congeners with thyroid
hormones varied. BDE-47 was positively asso-
ciated with testosterone levels.
Our finding of increased thyroglobulin
antibodies in 31% of participants with the
highest PBDE body burdens is potentially of
biologic significance because thyroglobulin
antibodies are found in 80–90% of patients
with chronic autoimmune thyroiditis and
50–60% of patients with Grave’s disease
(Marcocci and Marino 2005). The 8% preva-
lence of antibodies in the entire cohort is simi-
lar to rates seen in normal adult male
populations (Hollowell et al. 2002). Exposure
to PCBs, which are similar in structure to
PBDEs, has been associated with increased
antithyroperoxidase antibodies (Langer et al.
2007). The small number of cases of hypo- and
hyperthyroid disease limit our ability to draw
conclusions on effects of PBDEs on thyroid
disease, but the thyroglobulin results may indi-
cate an increased susceptibility to autoimmune
thyroiditis in PBDE-exposed persons.
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Table 2. Associations of hormones with ΣPBDEs and BDE-47: Pearson’s correlation coefﬁcients.
ΣPBDEs BDE-47
Hormone No. Measure Unadjusted Adjusteda Unadjusted Adjusteda
Ln TSH (μIU/mL) 304 r-Value –0.05 –0.10b –0.08 –0.14
p-Value 0.39 0.07 0.18 0.02
Total T3 (ng/dL) 305 r-Value –0.02 –0.04 –0.02 –0.04
p-Value 0.68 0.44 0.79 0.51
Ln free T3 (pg/mL) 306 r-Value –0.05 –0.06 –0.003 –0.01
p-Value 0.35 0.32 0.95 0.90
Ln rT3 (ng/dL) 304 r-Value 0.22 0.14 0.21 0.12c
p-Value < 0.0001 0.02 0.0003 0.04
Total T4 (μg/dL) 307 r-Value 0.10 0.12d 0.07 0.09
p-Value 0.07 0.03 0.21 0.12
Free T4 (ng/mL) 308 r-Value 0.13 0.16 0.09 0.13
p-Value 0.03 0.005 0.12 0.03
Ln urinary total T4 (pg/mL)e 268 r-Value 0.20 0.25 0.19 0.25
p-Value 0.001 < 0.0001 0.002 < 0.0001
TBG (μg/mL) 303 r-Value 0.04 0.05 0.02 0.02
p-Value 0.46 0.39 0.78 0.73
TBG-bound T4 (%) 267 r-Value –0.08 –0.11 –0.07 –0.11f
p-Value 0.18 0.06 0.27 0.08
Albumin-bound T4 (%) 267 r-Value 0.07 0.11g 0.05 0.11g
p-Value 0.26 0.06 0.37 0.08
Testosterone (ng/mL) 307 r-Value –0.06 –0.01 –0.01 0.06
p-Value 0.26 0.86 0.81 0.28
Ln SHBG (nmol/L) 269 r-Value 0.04 0.04 0.05 0.05
p-Value 0.47 0.54 0.41 0.44
SHBG-bound testosterone (%) 269 r-Value –0.02 –0.04 –0.03 –0.05
p-Value 0.73 0.49 0.62 0.38
aAdjusted for age, BMI, and serum lipids. Unless otherwise noted, signiﬁcance of adjusted models did not change with
further adjustment for the following covariates (added individually to model): smoking, alcohol use, antilipid medications,
beta blocker medications, furosamide medication, Great Lakes sport ﬁsh meals in the past year, sport ﬁsh meals in the
past year, ln ΣPCBs, ln DDE, years consuming sport ﬁsh meals, years consuming Great Lakes sport ﬁsh meals, and HA1c
level. Unless otherwise noted, signiﬁcance of adjusted models for thyroid hormones did not change with further adjust-
ment for testosterone level, ln SHBG level, and SHBG-bound testosterone level. bSigniﬁcant with further adjustment for
Great Lakes ﬁsh meals or sport ﬁsh meals in the last year (r = –0.12, p = 0.04). cBorderline signiﬁcant (0.05 < p < 0.10) with
further adjustment for HA1c, ln SHBG, SHBG-bound testosterone, or ln DDE.dBorderline signiﬁcant (0.05 < p < 0.10) with
further adjustment for alcohol consumption, Great Lakes fish meals in the last year, ln SHBG, or SHBG-bound testos-
terone. eAdjusted for urinary creatinine. fSignificant with further adjustment for testosterone (r = –0.12, p = 0.05).
gSigniﬁcant after exclusion of two extreme outliers for T4-bound albumin (r = 0.13, p = 0.03).
Figure 1. β-Coefﬁcients and 95% CIs from regression models for associations of individual ΣPBDE quar-
tiles with hormone levels. p-Values are from regression models for associations of ordinal ΣPBDE quartile
variables with hormone levels. All models adjusted for age, BMI, and serum lipids. Urinary total T4 was
also adjusted for urinary creatinine.
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p for trend = 0.20To our knowledge, epidemiologic data on
the effects of PBDEs on thyroid hormones in
adults is limited to four published studies.
First, a longitudinal study of 11 electronic
recycling employees found no signiﬁcant asso-
ciations of BDE congeners with TSH, total
T3, or free T4, but did note nonsignificant
trends for increasing free T4 with BDEs 28,
153, and 183 (Julander et al. 2005). Second,
free T4 and TSH were not signiﬁcantly asso-
ciated with PBDEs in 36 New York anglers,
although the associations of BDE congeners
with free T4 were consistently positive
(Bloom et al. 2008), and the authors esti-
mated that 318 persons would be required to
reach significance for the association of
ΣPBDEs with free T4. Third, Hagmar et al.
(2001) found a significant negative associa-
tion of BDE-47 with TSH but no signiﬁcant
association with free and total T3 and T4 in
110 men with high consumption of ﬁsh from
the Baltic Sea. Our results are consistent with
the decreased TSH in Hagmar et al.’s study
and with the positive direction of the free T4
associations of Bloom et al. (2008) and
Julander et al. (2005). Fourth, Yuan et al.
(2008) found higher TSH levels in electronic
waste workers compared with unexposed per-
sons, but PBDE exposures levels were sub-
stantially higher in that study than in our ﬁsh
consumer cohort.
Our findings of a positive association of
PBDEs with T4 and free T4 are not, however,
consistent with results of laboratory animal
studies. In rats and mice, PBDE mixtures and
BDE-47 have been shown to decrease T4 and
free T4 (Hallgren et al. 2001; Hallgren and
Darnerud 2002; Stoker et al. 2004; van der
Ven et al. 2008; Zhou et al. 2001, 2002). T3
was also decreased in some studies, but to a
lesser extent than total T4 (Zhou et al. 2001),
and TSH was not affected, except in a 31-day
exposure in male rats that had decreased TSH
(Stoker et al. 2004). It is not clear why our
results are inconsistent with decreased T4
found in PBDE-exposed laboratory animals.
Thyroid hormone regulation is similar in verte-
brates, but some functions differ by species.
For example, more T3 is produced by the thy-
roid in rats than in that of humans (40% vs.
20%), increasing the importance of deiodi-
nases in controlling T3 levels in humans. In
addition, TTR is the dominant binding pro-
tein in rats, whereas most thyroid hormone cir-
culates bound to TBG in humans. Rats are
more sensitive to effects of PBDEs on thyroid
hormones than are mice (Hallgren et al. 2001).
Inconsistencies could also be related to gener-
ally higher exposure levels in animals, younger
life stage at exposure, and congener-specific
effects. Mice exposed to BDE-209 had
decreased T3 but not T4 (Tseng et al. 2008).
Finally, there may be substantial differences in
the effects of acute versus chronic exposure.
A major strength of our study is the meas-
urement of speciﬁc hormones and BDE con-
geners, which may offer insights into potential
biological pathways. The analysis of the inde-
pendence of associations between thyroid hor-
mones and PBDEs regarding other measured
thyroid hormones suggests independent path-
ways for PBDE effects on urinary T4 levels and
T4 serum protein binding proportions, whereas
changes in rT3, total T4, free T4, total T3, and
TSH were interrelated. BDE-congener–speciﬁc
relationships also support different pathways,
with associations of BDEs 47, 99, 100, and 153
with urinary T4, BDEs 100 and 153 with T4
serum protein binding proportions, and BDEs
99 and 153 with rT3, total T4, and free T4.
The association of PBDEs with rT3 sug-
gests that PBDEs may affect thyroid hormone
deiodinases. Deiodinases play a key role in
control of cellular levels of T3 (Bianco and
Kim 2006). D2 deiodinase removes iodide
from outer ring of thyroid hormones (meta
position), converting T4 to T3, whereas D3
deiodinase removes an iodide from the inner
ring (ortho position) converting T4 to rT3. D1
can remove iodide from the inner and outer
PBDEs and hormones in adult males
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Table 3. Associations of hormones with BDE-47, BDE-99, BDE-100, and BDE-153 tertiles. 
Hormone Measure BDE-47 BDE-99 BDE-100 BDE-153
Ln TSH (μIU/mL) β for tertile 2a –0.14* –0.07 –0.05 0.06
β for tertile 3 –0.14* –0.10 –0.06 –0.02
p-Value for trendb 0.08 0.27 0.42 0.96
Total T3 (ng/dL) β for tertile 2 –2.49 –2.78 –5.61** –3.34
β for tertile 3 –4.33** –0.21 –1.27 –3.83*
p-Value for trend 0.02 0.84 0.18 0.04c
Ln free T3 (pg/mL) β for tertile 2 –0.04 0.01 –0.004 0.03
β for tertile 3 –0.07 –0.03 –0.05 –0.15**
p-Value for trend 0.18 0.55 0.47 0.04d
Ln rT3 (ng/dL) β for tertile 2 0.03 0.01 –0.04 0.04
β for tertile 3 0.09* 0.13** 0.11** 0.12**
p-Value for trend 0.06e 0.009 0.11 0.03f
Total T4 (μg/dL) β for tertile 2 –0.17 –0.15 –0.25 0.13
β for tertile 3 –0.01 0.32** 0.24 0.38**
p-Value for trend 0.92 0.06g 0.44 0.04h
Free T4 (ng/mL) β for tertile 2 –0.004 0.02 –0.03 0.03
β for tertile 3 0.04 0.10** 0.07** 0.10**
p-Value for trend 0.25 0.002 0.13 0.009
Urinary total T4 (pg/mL)i β for tertile 2 0.02 –0.03 0.06 0.03
β for tertile 3 0.30** 0.30** 0.24** 0.20**
p-Value for trend 0.0007 0.0009 0.01 0.06j
TBG (μg/mL) β for tertile 2 –0.32 –1.80** –1.17* –0.56
β for tertile 3 –0.69 –0.68 0.19 0.07
p-Value for trend 0.28 0.22 0.79 0.88
TBG-bound T4 (%) β for tertile 2 0.03 –1.05 –2.14** 1.23
β for tertile 3 –1.29* –0.77 –1.76** –1.78**
p-Value for trend 0.10k 0.29 0.008 0.17
Albumin-bound T4 (%) β for tertile 2 –0.59 0.93 1.67** –0.94
β for tertile 3 1.03 0.65 1.52** 1.58**
p-Value for trend 0.16 0.34 0.02 0.15
Testosterone (ng/mL) β for tertile 2 0.32** 0.33** –0.11 0.31*
β for tertile 3 0.36** 0.21 –0.18 –0.25
p-Value for trend 0.02l 0.16 0.25 0.46
Ln SHBG (nmol/L) β for tertile 2 –0.13 –0.20* –0.08 0.10
β for tertile 3 0.05 –0.01 0.03 –0.09
p-Value for trend 0.64 0.88 0.99 0.66
SHBG-bound testosterone (%) β for tertile 2 –1.49 –1.81* 1.49 1.02
β for tertile 3 –1.24 –1.38 –0.34 –0.64
p-Value for trend 0.22 0.16 0.90 0.81
aβ-Coefﬁcient estimate from linear regression for association of BDE tertile with hormone level, adjusted for age, BMI, and
serum lipids. Unless otherwise noted, signiﬁcance of adjusted models did not change with further adjustment for the fol-
lowing covariates (added individually to model): smoking, alcohol use, antilipid medications, beta blocker medications,
furosamide medication, Great Lakes sport ﬁsh meals in the past year, sport ﬁsh meals in the past year, ln ΣPCBs, ln DDE,
years consuming sport ﬁsh meals, years consuming Great Lakes sport ﬁsh meals, and HA1c level. Unless otherwise noted,
significance of adjusted models for thyroid hormones did not change with further adjustment for testosterone level, ln
SHBG level, and SHBG-bound testosterone level. bp-Value from linear regression model for ordinal BDE tertile variable
indicating trend over BDE tertiles.cBorderline signiﬁcant (0.05 < p < 0.10) with further adjustment for years consuming sport
ﬁsh or years consuming Great Lakes sport ﬁsh. dBorderline signiﬁcant (0.05 < p < 0.10) with further adjustment for smoking,
alcohol use, or years consuming Great Lakes sport ﬁsh. eSigniﬁcant with exclusion of extreme hormone outliers or with fur-
ther adjustment for smoking.fBorderline signiﬁcant (0.05 < p < 0.10) with further adjustment for HA1c, ln SHBG, or SHBG-
bound testosterone. gSignificant with further adjustment for years consuming sport fish or Great Lakes sport fish.
hBorderline signiﬁcant (0.05 < p < 0.10) with further adjustment for HA1c, ln SHBG, SHBG-bound testosterone, smoking,
alcohol use, or Great Lake sport ﬁsh meals in last year. iAdjusted for urinary creatinine. jSigniﬁcant with further adjustment
for years consuming sport ﬁsh or beta blocker use. kSigniﬁcant with further adjustment for testosterone levels. lBorderline
signiﬁcant (0.05 < p < 0.10) with further adjustment for HA1c or alcohol use.  *Individual tertile 0.05 < p < 0.10. **Individual
tertile p < 0.05. rings of thyroid hormones. Changes in deiodi-
nase activity can affect circulating hormone
levels, as demonstrated by studies of mice car-
rying deletion mutations. For example, mice
carrying deletion mutations in D2 have ele-
vated T4 and TSH but no changes in T3
(Schneider et al. 2001), those with D1 muta-
tions have elevated T4 and rT3 but no change
in T3 and TSH (Schneider et al. 2006),
whereas those with D3 mutations are hypothy-
roid with decreased T4 and T3 but no change
in TSH (Hernandez et al. 2006). These studies
suggest that inhibition of outer ring deiodi-
nases, most likely D1, by PBDEs could
account for the increased T4 and rT3 in our
participants with higher exposures. A possible
mechanism is competitive inhibition of outer
ring deiodinase by BDEs. Evidence that outer
ring deiodinases in fish may debrominate
BDE-99 to BDE-47 by removal of a bromine
from the meta position (Benedict et al. 2007),
as well as our ﬁnding that BDEs 99 and 153,
both of which have a bromine in the meta
position, were positively associated with rT3,
free T4, and total T4, supports this hypothesis.
The negative relationship of PBDEs with TSH
might be a normal feedback response to ele-
vated T4 levels. Decreased production of total
T3 could also be a consequence of decreased
outer ring deiodinase activity, although mice
with outer ring deiodinase deletion mutations
did not have abnormal T3 levels.
The strongest PBDE association we
observed was related to urinary total T4 levels.
Urinary total T4 levels are not routinely
assessed clinically. The increase we found,
however, is consistent with the noted increases
in serum free T4 and albumin-bound T4,
although the association of urinary T4 with
PBDEs was independent of serum free T4 and
albumin-bound T4. Future studies could assess
effects of PBDEs on urinary thyroid hormone
metabolites as a potential mechanism.
The associations of PBDEs with T4 serum
protein binding proportions suggest that
PBDEs could be displacing T4 from TBG.
Hydroxylated BDE metabolites were able to
bind to TTR in vitro (Hamers et al. 2006),
and TTR in serum from BDE-47–treated rats
showed decreased binding to 125I-T4 serum
compared with serum from untreated rats
(Hallgren and Darnerud 2002). However, to
our knowledge, the potential for BDE con-
geners and metabolites to compete with T4
binding to TBG has not been tested. 
Steroid hormones can affect thyroid hor-
mones through changes in TBG production.
We did not ﬁnd that testosterone levels modi-
fied the effects of PBDEs on thyroid hor-
mones, but testosterone and SHBG did
confound several associations of PBDEs and
thyroid hormones. In addition, we found a
positive association of testosterone with
BDE-47. Hagmar et al. (2001) did not find
associations of BDE-47 with free testosterone,
follicle-stimulating hormone, luteinizing hor-
mone, or prolactin in men. In male rats, the
onset of prenuptial separation was delayed and
ventral prostate and seminal vesicle weights
were decreased, but luteinizing hormone and
testosterone were not changed by PBDE expo-
sure (Stoker et al. 2004). However, Stoker
et al. (2005) found increased luteinizing hor-
mone and a trend for increased steroid con-
centrations in PBDE-exposed adult male rats,
and Lilienthal et al. (2006) observed that
testosterone was decreased in male pups pre-
natally exposed to BDE-99. BDE congeners,
in particular BDE-100, are androgen antago-
nists in vitro (Hamers et al. 2006; Stoker et al.
2005).
Although we excluded persons with dia-
betes from the hormone analyses, our data
suggest that the effects of PBDEs on rT3, free
T4, and albumin- and TBG-bound T4 are
stronger in persons with higher HA1c levels,
which could place persons with moderately
increased blood glucose at higher risk of thy-
roid hormone disruption by PBDEs. rT3 is
increased by fasting, malnutrition, and poorly
controlled diabetes. Alternatively, changes in
thyroid hormones may affect blood glucose
(Chidakel et al. 2005).
Our results also suggest that ﬁsh consump-
tion may modify the effect of PBDEs on thy-
roid function. We saw a stronger effect of
PBDEs on rT3 and albumin-bound T4 among
infrequent consumers and stronger effects on
TSH among frequent sport fish consumers.
Furthermore, some associations of PBDEs
with hormones were modified by consump-
tion of sports ﬁsh, but not by PCB or DDE
body burdens. These findings are consistent
with an interaction between PBDEs and other
contaminants in ﬁsh on thyroid hormones.
The strengths of the present study include
the use of a large, well-deﬁned cohort; assess-
ment of multiple hormones; and consideration
of other environmental exposures that can
affect thyroid hormones. Our conclusions are
limited by those of any cross-sectional investi-
gation. Although our results are inconsistent
with animal studies, they are consistent with
several human studies. The associations we
found were relatively weak, and the highest
proportion of hormone variation explained by
Turyk et al.
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Table 4. Associations of thyroid hormones with ΣPBDEs: confounding of signiﬁcant associations by other
thyroid hormones. 
Association of thyroid hormone with ΣPBDEs with adjustmenta
Hormone Unadjusted Urinary T4 Albumin-bound T4 TSH Total T4 Free T4 rT3 Total T3
Ln urinary T4
βb 0.21 — 0.21 0.20 0.20 0.20 0.21 0.22
p-Valueb 0.001 — 0.0001 0.001 0.001 0.001 0.001 0.001
Albumin-bound T4
β 0.79 0.94 — 0.76 0.91 0.83 0.93 0.72
p-Value 0.04 0.02 — 0.04 0.01 0.03 0.01 0.05
Ln TSH
β –0.10 –0.07* –0.09 — –0.08* –0.09 –0.10 –0.10
p-Value 0.04 0.18 0.08 — 0.10 0.07 0.04 0.03
Total T4
β 0.21 0.17 0.24 0.10* — 0.01* 0.19 0.24
p-Value 0.03 0.11 0.02 0.24 — 0.88 0.05 0.008
Free T4
β 0.054 0.046 0.053 0.063 0.026* — 0.038* 0.069*
p-Value 0.005 0.02 0.006 0.002 0.06 — 0.04 0.003
Ln rT3
β 0.071 0.067 0.076 0.067 0.043* 0.040* — 0.067
p-Value 0.02 0.05 0.02 0.03 0.15 0.10 — 0.03
Total T3
β –1.50 –2.53* –1.81* –1.53 –1.65 –1.93* –1.51 —
p-Value 0.03 0.001 0.02 0.03 0.01 0.005 0.03 —
aAll linear regression were adjusted for age, BMI, and serum lipid; urinary T4 was also adjusted for creatinine; and TSH
models were also adjusted for Great Lakes ﬁsh meals. Extreme outliers for albumin-bound T4 were excluded for albumin-
bound T4 models. Ordinal variables for ΣPBDE quartiles were used in total T3 models. bβ-Coefﬁcient and p-value for ΣPBDEs
from linear regression model predicting hormone levels. *β-Coefﬁcient change of > 20% with control for second hormone.
Table 5. Age-adjusted odds of thyroid disease and thyroglobulin antibodies with high PBDE exposure in
full cohort of 405 men.
All  ΣPBDE > 95th percentilea ΣPBDE > 90th percentileb
Condition No./total (%) No./total (%) OR (95% CI) No./total (%) OR (95% CI)
Any thyroid diseasec 20/405 (5) 1/20 (5) 1.0 (0.1–7.9) 4/40 (10) 2.4 (0.8–7.9)
Hypothyroid disease 14/405 (3.5) 0/20 (0) — 2/40 (5) 1.7 (0.4–8.2)
Hyperthyroid disease 5/405 (1.2) 1/20 (5) 4.5 (0.5–42.9) 2/40 (5) 5.7 (0.9–36.4)
Thyroglobulin antibodies 27/348 (7.8) 5/16 (31.3) 6.1 (1.9–19.2) 5/36 (13.9) 1.9 (0.7–5.5)
aPBDE 95th percentile = 1.47 ng/g. bPBDE 90th percentile = 0.78 ng/g. cAny thyroid disease includes hypothyroidism,
hyperthyroidism, goiter, Graves’ disease, Hashimoto’s disease, and thyroid tumor.PBDEs and hormones in adult males
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PBDE was approximately 6% for urinary T4
(r = 0.25). There were some inconsistencies
between results of models with continuous
and ordinal exposure variables, with effects
seen only in highest exposure category for
some hormones. This pattern might be related
to the extremely skewed distribution of
PBDEs in the study cohort (Table 1). In addi-
tion, some hormone parameters show incon-
sistencies between models of ΣPBDEs and
individual BDE congeners, which may be
explained by congener-speciﬁc effects, as sup-
ported by animal and in vitro data.
Although PBDE levels are lower than
PCB or DDE levels, PBDE body burdens are
increasing (Schecter et al. 2005). Older adults,
who have a high risk of thyroid disease, are
more likely to have BDE-47 levels above the
95th percentile level of 291 ng/g lipid (Sjodin
et al. 2008). In the present study, exposures
were similar to those of the U.S. population
(Anderson et al. 2008). With increasing
PBDE body burdens, we found increases in
T4, but decreases in T3 and TSH. In addition,
thyroglobulin antibodies were higher in men
with the highest PBDE body burdens. This is
the first large study to link PBDE exposure
with changes in thyroid antibodies and thyroid
hormone homeostasis in men.
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